The US Food and Drug Administration (FDA) has issued several warning letters to pharmaceutical manufacturers in India and ...

which included “multiple microbiological contamination events,” the FDA noted. The French pharma also failed to show that its production process can reproducibly manufacture an API to certain ...

Lupin API Plus SBU head, global chief financial officer and executive director Ramesh Swaminathan stated: “We are committed to providing affordable and high-quality treatments for patients worldwide.

With pharmaceutical companies heavily investing in R&D and precision medicine, the demand for high-quality specialty APIs is ...

It will enable researchers and enterprises to rapidly understand and put their data to work, and thereby will be a huge boon for drug discovery. Additionally, the new API that the company is ...